OKOhman Kwon

Ohman Kwon

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Ohman Kwon has a total of 77 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Sphingosine-1-phosphate receptor 1 signaling stimulates human pluripotent stem cell-derived cardiomyocyte differentiation and maturation

    by Won Dong Yu, Seul-Gi Lee, Kwang Bo Jung, Sung-Ae Hyun, Young-Dae Kim, Ye Seul Son, Hana Lee, Hyun-Soo Cho, Dae-Soo Kim, Kyung Jin Lee, et al.

    The development of human-relevant in vitro cardiac models is essential for evaluating cardiotoxicity and drug efficacy. Although wingless-related integration site signaling-based protocols have enabled cardiomyocyte (CM) differentiation from pluripotent stem cells, issues such as low efficiency, immature phenotype, and variability across cell lines remain to be resolved. Here, we present an improved differentiation strategy that robustly enhances both the efficiency and functional maturity of CMs, comparable to the functional characteristics of human adult myocardial tissue. Although fetal bovine serum enhanced differentiation, we disclosed that the interaction between sphingosine-1-phosphate (S1P) and its receptor S1PR1 is a major contributor. Gene-based and protein-based analyses and electrophysiological analysis via multielectrode array confirmed that activation of S1PR1 using S1P or its agonist SEW2871 increased the generation of spontaneously beating CMs, whereas S1PR1-deficient pluripotent stem cells exhibited impaired differentiation and functional maturity of S1P-S1PR1-derived CMs. Furthermore, we observed improved cardiac function and reduced fibrosis in a myocardial infarction mouse model induced by left descending artery ligation following transplantation of CMs differentiated more robustly by treatment with S1P or SEW2871. Collectively, S1PR1 activator-treated CMs offer a cost-effective platform for drug discovery and regenerative medicine.

  • Open Access

    Author Correction: Chemically-defined and scalable culture system for intestinal stem cells derived from human intestinal organoids

    by Ohman Kwon, Hana Lee, Jaeeun Jung, Ye Seul Son, Sojeong Jeon, Won Dong Yu, Naeun Son, Kwang Bo Jung, Eunho Choi, In-Chul Lee, et al.


  • Open Access

    Drug-induced gastrointestinal toxicity and barrier integrity: cytoskeleton-mediated impairment in a clinically relevant human intestinal epithelium model

    by Won Dong Yu, Sugi Lee, Hyun-Soo Cho, Ohman Kwon, Jung Hwa Lim, Cho-Rok Jung, Byunghyun Jang, Kyung Jin Lee, Jongman Yoo, Dae-Soo Kim, et al.

    Drug-induced gastrointestinal (GI) toxicity is common, dose-limiting and difficult to predict using conventional Caco-2-based assays that lack physiological relevance. Here we evaluate a transepithelial electrical resistance (TEER) assay using nontransformed human intestinal epithelial cells (hIECs), derived from human pluripotent stem cells, which superiorly recapitulated epithelial diversity and polarity as well as intestinal barrier function. Across 17 clinically relevant compounds (cell cycle inhibitors, tyrosine kinase inhibitors and nonsteroidal anti-inflammatory drugs), the hIEC TEER assay outperformed ATP cell viability assays, and the Caco-2 TEER assay (AUC of 0.96 for hIEC TEER, 0.72 for Caco-2 TEER and ≤0.69 for cell viability assays) correlated with integrated GI toxicity scores using a ≥50% TEER reduction cutoff (sensitivity 92%, specificity 100% and accuracy 94%). Drug exposure was quantified by calculating the margin of safety (IC 15 : C max ) and a lumen–surrogate margin of safety for oral agents. For mechanistic insight, transcriptomic analysis using representative chemotherapeutics (paclitaxel and docetaxel) showed the downregulation of cytoskeleton-related pathways, including cytoskeleton in muscle cells, cell adhesion molecules and extracellular matrix–receptor interaction, linking microtubule-targeting chemotherapy to intestinal barrier impairment. This platform provides a robust tool that combines predictive accuracy with the evaluation of cytoskeleton-mediated barrier impairment, enabling the early identification of drug-induced GI toxicity.


  • Open Access

    Xenogeneic-free culture of human intestinal stem cells on functional polymer-coated substrates for scalable, clinical-grade stem cell therapy

    by Seonghyeon Park, Ohman Kwon, Hana Lee, Younghak Cho, Jemin Yeun, Sung Hyun Yoon, Sang Yu Sun, Yubin Huh, Won Dong Yu, Sohee Park, et al.

    The need for basement membrane extract (BME) with undefined constituents, such as Matrigel, for intestinal stem cell (ISC) culture in traditional systems poses a significant barrier that must be overcome for the development of clinical-grade, scalable, ready-to-use ISCs. Here, we propose a functional polymer-based xenogeneic-free dish for the culture of intestinal stem cells (XF-DISC), ensuring substantially prolonged maintenance of ISCs derived from 3-dimensional human intestinal organoids (ISCs3D-hIO). XF-DISC enables remarkable expandability, exhibiting a 24-fold increase in cell numbers within 30 days, with long-term maintenance of ISCs3D-hIO for more than 30 consecutive passages (>210 days). In addition, XF-DISC is fully compatible with a cell banking system. Notably, human pluripotent stem cell-derived ISCs3D-hIO cultured on XF-DISC are successfully transplanted into intestinal injury and inflammation mouse models, leading to engraftment and regeneration of damaged mouse intestinal epithelium. As a reliable and scalable xenogeneic-free ISC3D-hIO culture method, XF-DISC is highly promising for the development of regenerative ISC therapy for human intestinal diseases.


  • Open Access

    Helicobacter pylori VacA-induced mitochondrial damage in the gastric pit cells of the antrum and therapeutic rescue

    by Ye Seul Son, Yong Hwan Kwon, Moo-Seung Lee, Ohman Kwon, Yu-Jin Jeong, Seon Ju Mun, Sojeong Jeon, Ji Hye Park, Man-Hoon Han, Jae-Sung Bae, et al.


  • Open Access

    Chemically-defined and scalable culture system for intestinal stem cells derived from human intestinal organoids

    by Ohman Kwon, Hana Lee, Jaeeun Jung, Ye Seul Son, Sojeong Jeon, Won Dong Yu, Naeun Son, Kwang Bo Jung, Eunho Choi, In-Chul Lee, et al.

    Three-dimensional human intestinal organoids (hIO) are widely used as a platform for biological and biomedical research. However, reproducibility and challenges for large-scale expansion limit their applicability. Here, we establish a human intestinal stem cell (ISC) culture method expanded under feeder-free and fully defined conditions through selective enrichment of ISC populations (ISC 3D-hIO ) within hIO derived from human pluripotent stem cells. The intrinsic self-organisation property of ISC 3D-hIO , combined with air-liquid interface culture in a minimally defined medium, forces ISC 3D-hIO to differentiate into the intestinal epithelium with cellular diversity, villus-like structure, and barrier integrity. Notably, ISC 3D-hIO is an ideal cell source for gene editing to study ISC biology and transplantation for intestinal diseases. We demonstrate the intestinal epithelium differentiated from ISC 3D-hIO as a model system to study severe acute respiratory syndrome coronavirus 2 viral infection. ISC 3D-hIO culture technology provides a biological tool for use in regenerative medicine and disease modelling.


  • Open Access

    Limosilactobacillus reuteri DS0384 promotes intestinal epithelial maturation via the postbiotic effect in human intestinal organoids and infant mice

    by Hana Lee, Kwang Bo Jung, Ohman Kwon, Ye Seul Son, Eunho Choi, Won Dong Yu, Naeun Son, Jun Hyoung Jeon, Hana Jo, Haneol Yang, et al.

    Little is known about the modulatory capacity of the microbiota in early intestinal development. We examined various intestinal models that respond to gut microbial metabolites based on human pluripotent stem cell-derived human intestinal organoids (hIOs): physiologically relevant in vitro fetal-like intestine, intestinal stem cell, and intestinal disease models. We found that a newly isolated Limosilactobacillus reuteri strain DS0384 accelerated maturation of the fetal intestine using 3D hIO with immature fetal characteristics. Comparative metabolomic profiling analysis revealed that the secreted metabolite N-carbamyl glutamic acid (NCG) is involved in the beneficial effect of DS0384 cell-free supernatants on the intestinal maturation of hIOs. Experiments in an intestinal stem cell spheroid model and hIO-based intestinal inflamed model revealed that the cell-free supernatant from DS0384 comprising NCG promoted intestinal stem cell proliferation and was important for intestinal protection against cytokine-induced intestinal epithelial injury. The probiotic properties of DS0384 were also evaluated, including acid and bile tolerance and ability to adhere to human intestinal cells. Seven-day oral administration of DS0384 and cell-free supernatant promoted the intestinal development of newborn mice. Moreover, NCG exerted a protective effect on experimental colitis in mice. These results suggest that DS0384 is a useful agent for probiotic applications and therapeutic treatment for disorders of early gut development and for preventing intestinal barrier dysfunction.


  • Open Access

    The development of a functional human small intestinal epithelium model for drug absorption

    by Ohman Kwon, Kwang Bo Jung, Kyeong-Ryoon Lee, Ye Seul Son, Hana Lee, Jong-Jin Kim, Kwangho Kim, Seop Lee, Yoo-Kyung Song, Jaeeun Jung, et al.

    Directed differentiation of hPSCs and transition from 3D intestinal organoids into functional hIECs.